Hearing aid manufacturers unconcerned about potential OTC disruptions

The newly proposed regulatory framework in the US for the over-the-counter sales channel of hearing aids is of no concern to Danish hearing healthcare companies, who predict Americans will continue to prioritize professional guidance over cheaper devices.

Photo: Joe Raedle/AFP/Ritzau Scanpix

After much anticipation from Danish hearing aid manufacturers, the US Food and Drug Administration (FDA) has announced its proposal for new rules concerning the over-the-counter (OTC) sales of hearing aids.

The creation of the OTC sales channel for hearing aids in the US has been underway for some time, and should have come into force in August of last year. However, the plans have been delayed several times.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Rumored GN purchase unlikely but not impossible, say analysts

A low value assessment, a high structural value, and no dominant shareholders make GN Group a reasonable investment case for international private equity firms and industrial players. But just how likely is it? Analysts reveal their best bets for what a GN acquisition could look like.

New CFO wants to shake things up at WSA

A mere month into her new job, Marianne Wiinholt, WS Audiology’s fifth chief financial officer since the firm was established through a merger in 2019, is heralding great structural changes.

Further reading

Related articles

Latest news

See all jobs